| scholarly article | Q13442814 |
| P50 | author | Kathryn A Cunningham | Q88279141 |
| Erica D Holliday | Q89928612 | ||
| Sandra D Comer | Q109482605 | ||
| Margaret Haney | Q61825350 | ||
| P2093 | author name string | F Gerard Moeller | |
| Noelle C Anastasio | |||
| Robert G Fox | |||
| Sonja J Stutz | |||
| Harshini Neelakantan | |||
| P2860 | cites work | Cue-reactivity and the future of addiction research | Q95811467 |
| Neurocircuitry of addiction | Q24647156 | ||
| Distribution of serotonin 5-HT2C receptors in the ventral tegmental area | Q24682104 | ||
| Relationship between Nonmedical Prescription-Opioid Use and Heroin Use | Q26772149 | ||
| Emergency Department Visits Involving Narcotic Pain Relievers | Q26858923 | ||
| Serotonin 5-HT2 receptor interactions with dopamine function: implications for therapeutics in cocaine use disorder | Q27015917 | ||
| Rational development of addiction pharmacotherapies: successes, failures, and prospects | Q27025533 | ||
| Meta-analysis of cue-reactivity in addiction research | Q28140862 | ||
| Neuroadaptation. Incubation of cocaine craving after withdrawal | Q28343773 | ||
| Serotonin 2C receptor activates a distinct population of arcuate pro-opiomelanocortin neurons via TRPC channels | Q28585910 | ||
| The reinstatement model of drug relapse: history, methodology and major findings | Q29616241 | ||
| Attentional bias for prescription opioid cues among opioid dependent chronic pain patients | Q30424153 | ||
| Pharmacologic mechanisms of serotonergic regulation of dopamine neurotransmission | Q30493133 | ||
| Functional status of the serotonin 5-HT2C receptor (5-HT2CR) drives interlocked phenotypes that precipitate relapse-like behaviors in cocaine dependence | Q30574997 | ||
| Augmented accumbal serotonin levels decrease the preference for a morphine associated environment during withdrawal | Q31657518 | ||
| Laboratory-induced cue reactivity among individuals with prescription opioid dependence | Q33761482 | ||
| Serotonin at the nexus of impulsivity and cue reactivity in cocaine addiction | Q33874819 | ||
| Cue-induced cocaine craving: neuroanatomical specificity for drug users and drug stimuli. | Q33923752 | ||
| 5-HT(2C) receptors localize to dopamine and GABA neurons in the rat mesoaccumbens pathway | Q33936895 | ||
| Serotonin 5-HT2C receptor protein expression is enriched in synaptosomal and post-synaptic compartments of rat cortex | Q34048779 | ||
| Addiction: decreased reward sensitivity and increased expectation sensitivity conspire to overwhelm the brain's control circuit | Q34132713 | ||
| Differential effects of the 5-HT(2A) receptor antagonist M100907 and the 5-HT(2C) receptor antagonist SB242084 on cocaine-induced locomotor activity, cocaine self-administration and cocaine-induced reinstatement of responding | Q34154263 | ||
| Cue-induced craving in dependence upon prescription opioids and heroin. | Q34180281 | ||
| The effects of exposure to drug-related cues in detoxified opiate addicts: a theoretical review and some new data | Q34223354 | ||
| Activation of G-Proteins by Morphine and Codeine Congeners: Insights to the Relevance of O- and N-Demethylated Metabolites at μ- and δ-Opioid Receptors | Q34274685 | ||
| The serotonin 2C receptor antagonist SB 242084 exhibits abuse-related effects typical of stimulants in squirrel monkeys | Q34280398 | ||
| Neurobiology of addiction | Q34390258 | ||
| Direct bidirectional μ-opioid control of midbrain dopamine neurons | Q34416532 | ||
| The 5-HT2C receptor agonist Ro60-0175 reduces cocaine self-administration and reinstatement induced by the stressor yohimbine, and contextual cues | Q34655896 | ||
| Opposing effects of 5-HT(2A) and 5-HT(2C) receptor antagonists in the rat and mouse on premature responding in the five-choice serial reaction time test | Q34659207 | ||
| Molecular characterization of a functional cDNA encoding the serotonin 1c receptor | Q34688040 | ||
| Lorcaserin, a novel selective human 5-hydroxytryptamine2C agonist: in vitro and in vivo pharmacological characterization | Q34746665 | ||
| Effects of direct- and indirect-acting serotonin receptor agonists on the antinociceptive and discriminative stimulus effects of morphine in rhesus monkeys | Q34797437 | ||
| Blockade of the serotonin 5-HT2A receptor suppresses cue-evoked reinstatement of cocaine-seeking behavior in a rat self-administration model | Q34971199 | ||
| Selective serotonin 5-HT(2C) receptor activation suppresses the reinforcing efficacy of cocaine and sucrose but differentially affects the incentive-salience value of cocaine- vs. sucrose-associated cues | Q35046675 | ||
| Lorcaserin, a 5-HT2C agonist, decreases nicotine self-administration in female rats | Q35188133 | ||
| Effects of an oxycodone conjugate vaccine on oxycodone self-administration and oxycodone-induced brain gene expression in rats | Q35207004 | ||
| Neuronal circuits underlying acute morphine action on dopamine neurons | Q35239670 | ||
| Compulsive-like responding for opioid analgesics in rats with extended access | Q35647339 | ||
| The 5-HT2C receptor agonist lorcaserin reduces nicotine self-administration, discrimination, and reinstatement: relationship to feeding behavior and impulse control | Q35837700 | ||
| Extinction training regulates neuroadaptive responses to withdrawal from chronic cocaine self-administration | Q35909931 | ||
| Effects of serotonin 2C receptor agonists on the behavioral and neurochemical effects of cocaine in squirrel monkeys | Q35913179 | ||
| Activation of serotonin 5-HT(2C) receptor suppresses behavioral sensitization and naloxone-precipitated withdrawal symptoms in heroin-treated mice | Q36244665 | ||
| Adjunctive counseling during brief and extended buprenorphine-naloxone treatment for prescription opioid dependence: a 2-phase randomized controlled trial | Q36314619 | ||
| Lorcaserin Reduces the Discriminative Stimulus and Reinforcing Effects of Cocaine in Rhesus Monkeys | Q36432310 | ||
| Intracranial self-administration of morphine into the ventral tegmental area in rats. | Q52294551 | ||
| Self-administration of small amounts of morphine through glass micropipettes into the ventral tegmental area of the rat | Q69793144 | ||
| Serotonin induces depolarization in lateral amygdala neurons by activation of TRPC-like current and inhibition of GIRK current depending on 5-HT(2C) receptor | Q87507960 | ||
| Role of hepatic blood flow and metabolism in the pharmacokinetics of ten drugs in lean, aged and obese rats | Q88115063 | ||
| Synergism between a serotonin 5-HT2A receptor (5-HT2AR) antagonist and 5-HT2CR agonist suggests new pharmacotherapeutics for cocaine addiction | Q36540945 | ||
| Incubation of cocaine cue reactivity associates with neuroadaptations in the cortical serotonin (5-HT) 5-HT2C receptor (5-HT2CR) system | Q36818400 | ||
| Activation of serotonin 5-HT(2C) receptor suppresses behavioral sensitization and naloxone-precipitated withdrawal symptoms in morphine-dependent mice | Q37200551 | ||
| Variation within the serotonin (5-HT) 5-HT₂C receptor system aligns with vulnerability to cocaine cue reactivity | Q37663627 | ||
| The clinical relevance of attentional bias in substance use disorders. | Q38105652 | ||
| Understanding opioid reward | Q38338668 | ||
| Therapeutic Potential of 5-HT2C Receptor Agonists for Addictive Disorders | Q38419892 | ||
| Stimulation of medial prefrontal cortex serotonin 2C (5-HT(2C)) receptors attenuates cocaine-seeking behavior | Q42034255 | ||
| Role of 5-hydroxytryptamine2C receptors in Ca2+-dependent ethanol potentiation of GABA release onto ventral tegmental area dopamine neurons | Q42176852 | ||
| Medication-assisted therapies--tackling the opioid-overdose epidemic | Q42218151 | ||
| The effects of heroin administration and drug cues on impulsivity | Q42362398 | ||
| Serotonin-dopamine interaction in the rat ventral tegmental area: an electrophysiological study in vivo | Q42493300 | ||
| m-Chlorophenylpiperazine excites non-dopaminergic neurons in the rat substantia nigra and ventral tegmental area by activating serotonin-2C receptors | Q42503089 | ||
| Extinction training regulates tyrosine hydroxylase during withdrawal from cocaine self-administration. | Q43551138 | ||
| Extinction-induced upregulation in AMPA receptors reduces cocaine-seeking behaviour | Q43756453 | ||
| Activation of 5-HT(2C) receptors reduces the locomotor and rewarding effects of nicotine | Q43769228 | ||
| Factors influencing the selection of hydrocodone and oxycodone as primary opioids in substance abusers seeking treatment in the United States | Q43926330 | ||
| Reinstatement and spontaneous recovery of cocaine-seeking following extinction and different durations of withdrawal | Q44190281 | ||
| Supersensitivity to opioid analgesics following chronic opioid antagonist treatment: Relationship to receptor selectivity | Q44334204 | ||
| Neurobiological substrates of cue-elicited craving and anhedonia in recently abstinent opioid-dependent males. | Q44340290 | ||
| Comparison of the in vitro efficacy of mu, delta, kappa and ORL1 receptor agonists and non-selective opioid agonists in dog brain membranes | Q44351728 | ||
| Fluoxetine suppresses morphine tolerance and dependence: modulation of NO-cGMP/DA/serotoninergic pathways. | Q44479255 | ||
| Injection of the 5-HT2C receptor agonist Ro60-0175 into the ventral tegmental area reduces cocaine-induced locomotor activity and cocaine self-administration | Q44686785 | ||
| Discriminative stimulus, reinforcing, physical dependence, and antinociceptive effects of oxycodone in mice, rats, and rhesus monkeys | Q44904151 | ||
| Evaluation of chemically diverse 5-HT₂c receptor agonists on behaviours motivated by food and nicotine and on side effect profiles | Q46240693 | ||
| Ultra-low-dose naltrexone suppresses rewarding effects of opiates and aversive effects of opiate withdrawal in rats | Q46595577 | ||
| Ultra-low-dose naltrexone reduces the rewarding potency of oxycodone and relapse vulnerability in rats | Q46719122 | ||
| 5-Hydroxytryptamine induced excitation and inhibition in the subthalamic nucleus: action at 5-HT(2C), 5-HT(4) and 5-HT(1A) receptors. | Q46757011 | ||
| Stimulation of 5-HT2C receptors attenuates cue and cocaine-primed reinstatement of cocaine-seeking behavior in rats | Q46909719 | ||
| The 5-HT(2C) receptor agonist lorcaserin reduces cocaine self-administration, reinstatement of cocaine-seeking and cocaine induced locomotor activity | Q47609891 | ||
| Ventral tegmental site of opiate reward: antagonism by a hydrophilic opiate receptor blocker | Q47734930 | ||
| Functional expression of the 5-HT1c receptor in neuronal and nonneuronal cells | Q48140272 | ||
| Alteration in regulation of serotonin release in rat dorsal raphe nucleus after prolonged exposure to morphine. | Q48434351 | ||
| Rewarding and psychomotor stimulant effects of endomorphin-1: anteroposterior differences within the ventral tegmental area and lack of effect in nucleus accumbens. | Q48511618 | ||
| Opioids excite dopamine neurons by hyperpolarization of local interneurons | Q48543154 | ||
| Activation of Serotonin 2C Receptors in Dopamine Neurons Inhibits Binge-like Eating in Mice | Q48574951 | ||
| Effects of the 5-HT2C receptor agonist Ro60-0175 and the 5-HT2A receptor antagonist M100907 on nicotine self-administration and reinstatement | Q48655865 | ||
| Conditioning factors in drug abuse: can they explain compulsion? | Q48722496 | ||
| Predictive validity of the extinction/reinstatement model of drug craving | Q48728065 | ||
| Changes in regional cerebral blood flow elicited by craving memories in abstinent opiate-dependent subjects | Q48770651 | ||
| Cue reactivity and effects of cue exposure in abstinent posttreatment drug users. | Q51092442 | ||
| Opioid Analgesics. | Q51098707 | ||
| Studies to investigate the role of 5-HT(2C) receptors on cocaine- and food-maintained behavior. | Q51372657 | ||
| Cue-induced reactivity, cortisol response and substance use outcome in treated heroin dependent individuals. | Q51861543 | ||
| Attentional bias predicts heroin relapse following treatment. | Q51913668 | ||
| Acute effect of methadone maintenance dose on brain FMRI response to heroin-related cues. | Q51970635 | ||
| Influence of 5-HT3 receptor antagonists and the indirect 5-HT agonist, dexfenfluramine, on heroin self-administration in rats. | Q52217110 | ||
| Further studies to examine the nature of dexfenfluramine-induced suppression of heroin self-administration. | Q52271266 | ||
| P433 | issue | 5 | |
| P921 | main subject | oxycodone | Q407535 |
| P304 | page(s) | 1065-1073 | |
| P577 | publication date | 2017-02-13 | |
| P1433 | published in | ACS Chemical Neuroscience | Q2819059 |
| P1476 | title | Lorcaserin Suppresses Oxycodone Self-Administration and Relapse Vulnerability in Rats | |
| P478 | volume | 8 |
| Q90457974 | Activation of GLP-1 receptors attenuates oxycodone taking and seeking without compromising the antinociceptive effects of oxycodone in rats |
| Q50227324 | Choice between delayed food and immediate opioids in rats: treatment effects and individual differences |
| Q52604833 | Design, Synthesis, and Characterization of 4-Undecylpiperidine-2-carboxamides as Positive Allosteric Modulators of the Serotonin (5-HT) 5-HT2C Receptor. |
| Q92439426 | Effect of the dopamine stabilizer (-)-OSU6162 on potentiated incubation of opioid craving after electric barrier-induced voluntary abstinence |
| Q89308612 | Effects of lorcaserin and buspirone, administered alone and as a mixture, on cocaine self-administration in male and female rhesus monkeys |
| Q58080217 | Effects of lorcaserin on reinstatement of responding previously maintained by cocaine or remifentanil in rhesus monkeys |
| Q90049870 | In Vivo and In Vitro Analyses of Novel Peptidomimetic Disruptors for the Serotonin 5-HT2C Receptor Interaction With Phosphatase and Tensin Homolog |
| Q47348330 | Inhibition of cocaine and 3,4-methylenedioxypyrovalerone (MDPV) self-administration by lorcaserin is mediated by 5-HT2C receptors in rats |
| Q45074434 | Innovative Therapeutic Intervention For Opioid Use Disorder. |
| Q98665131 | Learning from lorcaserin: lessons from the negative clinical trial of lorcaserin to treat cocaine use disorder |
| Q91882328 | Lorcaserin decreases the reinforcing effects of heroin, but not food, in rhesus monkeys |
| Q64977613 | NIDA's medication development priorities in response to the Opioid Crisis: ten most wanted. |
| Q47330880 | Pharmacological Modulation of 5-HT2C Receptor Activity Produces Bidirectional Changes in Locomotor Activity, Responding for a Conditioned Reinforcer, and Mesolimbic DA Release in C57BL/6 Mice |
| Q60305402 | Pimavanserin and Lorcaserin Attenuate Measures of Binge Eating in Male Sprague-Dawley Rats |
| Q47588598 | Role of impulsivity and reward in the anti-obesity actions of 5-HT2C receptor agonists |
| Q91749643 | Targeting the 5-HT2C Receptor in Biological Context and the Current State of 5-HT2C Receptor Ligand Development |
| Q47677518 | The behavioral pharmacology and therapeutic potential of lorcaserin for substance use disorders |
| Q47307050 | The dopamine motive system: implications for drug and food addiction |
Search more.